APP
MD icon

Avantax Planning Partners’s Pediatrix Medical MD Stock Holding History

Avantax Planning Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-205
Closed -$11K – 956
2018
Q1 		$11K Buy
+205
New +$11.2K ﹤0.01% 998

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Avantax Planning Partners's MD Position: Q2 2018 in Review

Avantax Planning Partners sold out of Pediatrix Medical (MD) in Q2 2018, closing a stake of 205 shares — an estimated $11K sold.

Avantax Planning Partners first reported a position in MD in Q1 2018 and held it in 1 quarter. The position peaked at $11K in Q1 2018. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

  • Avantax Planning Partners reported no remaining Pediatrix Medical position as of Q2 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 205 Pediatrix Medical shares in Q2 2018, an estimated $11K.
  • Avantax Planning Partners first reported a position in Pediatrix Medical in Q1 2018 and held it in 1 quarter.
  • Avantax Planning Partners's Pediatrix Medical position peaked at $11K in Q1 2018.
  • 322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.